Abeona Therapeutics Announces Participation in 8th Annual SVB Leerink Global Healthcare Conference Feb 22, 2019
Abeona Therapeutics to Present New Supportive Data for Novel Gene Therapies at WORLDSymposium™ Jan 31, 2019
Abeona Therapeutics Details Pathway for Advancing Lead Clinical Programs and Unveils New Cystic Fibrosis Program Born from Next Generation AIM™ Vector Platform at 2018 R&D Day Dec 6, 2018
Abeona Therapeutics and REGENXBIO Announce Worldwide Exclusive Licenses for the Treatment of Four Rare Lysosomal Storage Disorders Using NAV AAV9 Vector Nov 5, 2018